Background: Older adults taking multiple prescription and nonprescription drugs are at risk for medication use problems, yet there are few brief, self-administered screening tools designed specifically for them. Objective: The study objective was to develop and validate a patient-centered screener for community-dwelling older adults. Methods: In phase 1, a convenience sample of 57 stakeholders (older adults, pharmacists, nurses, and physicians) participated in concept mapping, using Concept System ® Global MAX TM , to identify items for a questionnaire. In phase 2, a 40-item questionnaire was tested with a convenience sample of 377 adults and a 24-item version was tested with 306 older adults, aged 55 and older, using Rasch methodology. In phase 3, stakeholder focus groups provided feedback on the format of questionnaire materials and recommended strategies for addressing problems. Results: The concept map contained 72 statements organized into 6 conceptual clusters or domains. The 24-item screener was unidimensional. Cronbach's alpha was .87, person reliability was acceptable (.74), and item reliability was high (.96). Conclusion: The MedUseQ is a validated, patient-centered tool targeting older adults that can be used to assess a wide range of medication use problems in clinical and community settings and to identify areas for education, intervention, or further assessment.
Introduction
There is substantial evidence that medication nonadherence, misuse, and abuse among older adults are significant problems [1] [2] [3] [4] that contribute to adverse drug reactions, leading to costly emergency care visits or hospitalizations, institutionalizations, morbidities, and deaths. [5] [6] [7] Age-related physiologic changes increase the risks of adverse drug reactions 7 and addiction, 3 and appropriate medication use can be challenging for those who experience declines in cognition, vision, or hearing and/or functional limitations. Those who take multiple prescription medications, as well as over-the-counter medications (OTCs; eg, nonsteroidal anti-inflammatory drugs or laxatives), and alternative health-care products (eg, dietary supplements, homeopathic remedies, or herbs), may be at heightened risk. 1, 4 The National Center for Patient Information and Education reports that 37% of those aged 60 and older used 5 or more prescription drugs. 1 A National Health and Social Life Survey found that 42% used at least 1 OTC medication and 49% of older adults use dietary supplements, 8 but little is known about how older adults use OTCs in conjunction with prescriptions. 9 Misuse and abuse of medications is also likely to increase as baby boomers age. 2, 3, 10 In 2013, 8 .0% of those aged 50 and older used opioids, 6.6% used tranquilizers, and 7.1% used stimulants for nonmedical purposes in 2013, with an increase in prevalence over the prior decade. 11 In addition, around 20% of older adults in a national survey used alcohol concurrently with medications that could put them at risk for drug-alcohol interactions. 12 The extent of medication use problems among older adults is likely underestimated, in part due to inadequate screening of this population. 2, 3, 9, 13 Effective screening of older patients' medication use can improve health-care providers' understanding of patients' beliefs and experiences, inform patientcentered medication management interventions, and motivate patients to consult with providers, potentially improving their health-related quality of life. [13] [14] [15] [16] [17] In 2014, prior to initiation of this 2-year study, we could not locate a brief, self-administered tool designed specifically for older adults to assess broadly defined medication use problems. One medication-related problem screener, 18 derived from the Drug Therapy Concerns Questionnaire, 16 addressed a range of medication use issues for patients in general, while other tools assessed patients who were specifically at risk of misuse and abuse of particular medications. 19, 20 For example, the Medication Adherence Scale was developed with patients having specific 21 and chronic conditions, 22 while the Medication Risk Questionnaire 23 was developed with an older population, but these tools address only a few adherence issues.
Objectives
The goal of this multiphase study was to develop and validate a brief, self-administered screening tool to identify medication use problems experienced by older adults, for use in clinical and community settings. Medication use problems included unintentional and intentional nonadherence, misuse or abuse of prescribed drugs, OTC medications, and alternative healthcare products. The specific objectives were to (1) generate a list of items for a screening questionnaire using Concept System ® Global MAX TM , 24 (2) field test the questionnaire and develop a shorter version, (3) determine the psychometric properties of the short version, using Rasch methodology, and (4) develop a companion educational piece for older adults. The institutional review board of CJE SeniorLife approved this study.
Methods
Phase 1 captured stakeholders' views regarding medication misuse and abuse via concept mapping methodology, using The Concept System Global MAX. Concept mapping uses an inductive process to generate "statements" describing a concept and a visual map of that concept through iterative review, feedback, and consensus building among study participants. 25 This method has been used for developing assessment tools for older adults [26] [27] [28] [29] and for opioid misuse and abuse. 20 Phase 2 included developing items derived from the concept mapping statements and conducting field tests of 2 versions of a medication use questionnaire, based on concept mapping results. Rasch analysis tests construct validity by examining dimensionality, the fit of items to the model, rating scale functionality, internal consistency, and appropriateness of the model for the target population. [30] [31] [32] It also produces a "map" displaying frequency of item endorsement.
In phase 3, focus groups provided input on the final format of questionnaire materials, including a companion educational piece comprised of strategies to address problems identified during the completion of the questionnaire.
Participant Recruitment
The study included 3 sets of stakeholders. Phase 1 (concept mapping, cognitive interviews, and focus groups) and phase 3 (focus groups) relied on convenience sampling of older adults recruited at community-based senior programs. Health-care professionals (pharmacists, nurses, and physicians) and social workers were recruited through professional contacts of the research team, a project advisory committee made up of professionals with expertise in problematic medication use, and a social worker listserv. Professionals were required to have worked with older adults. All participants lived or worked in the greater Chicagoland area. Researchers secured written informed consent from all participants of phases 1 and 3. The research team facilitated each focus group, using a structured question guide. One researcher served as a designated notetaker. Individual face-to-face cognitive interviews were conducted by 2 of the researchers, both experienced in cognitive interviewing. 33 During the interviews, respondents were asked to explain how they interpreted the questionnaire items, instructions, and response options.
In phase 2 (questionnaire field tests), researchers distributed questionnaires at senior centers, community-based organizations serving older adults, and senior housing facilities operated by the principal investigator's organization, with permission from each site. The 40-item and 24-item screeners were tested with different samples. Participation was voluntary. Participants did not provide signed consent as questionnaires were completed anonymously.
Concept Mapping and Questionnaire Development
Concept mapping began with a series of 4 stakeholder brainstorming sessions to elicit statements completing the prompt "a reason or way that older adults misuse or abuse prescription and nonprescription medications would be . . . ," along with a broad definition of medications that included prescriptions, OTCs, and alternative products. The list of generated statements was reviewed and reduced via discussions with advisory committee members and 4 cognitive interviews with stakeholders. A second group of participants was then asked to sort the reduced list of statements into groups based on statement similarity and also rate each statement on a scale of 1 to 4 (low to high), first for its prevalence among older adults and again for its importance for inclusion in a screening questionnaire for older adults. These tasks were either done on paper or on the Concept Systems Global MAX project website.
Concept Systems Global MAX creates a similarity matrix of all data sorts and uses multidimensional scaling to plot each statement in 2-dimensional space, called a "point map," where each point on the map represents a specific statement. It then uses hierarchical cluster analysis to enclose a set of points, creating a cluster map of the construct. 25 The proximity of points on the map corresponds to how frequently statements were sorted together by different participants, based on the supposition that the ideas expressed are similar in meaning. Concept System Global MAX also generates a mean rating score for each statement along each rating dimension, displayed as a bivariate 4-quadrant graph showing the relative position of each statement according to its mean rating along each dimension (prevalence and importance). The rating results were used to identify issues judged to be important to include as items in a screening questionnaire. The face validity of a draft questionnaire was tested with 2 stakeholder focus groups, one with older adults and one with professionals.
Field Test and Rasch Analysis
During phase 2, participants in field tests of both long and short versions received a questionnaire with a cover sheet explaining the study purpose and contact information, eligibility criteria, and instructions for completing and returning the questionnaire on site or via US mail. Participants were offered a snack, drink, and pens, whether or not they completed a questionnaire. In the long version field test, participants were eligible to complete a questionnaire if they were 55 years or older, taking at least 1 prescription or nonprescription medication on a regular basis, and could read English, based on their own judgment. The results of this field test were then used to create a short version, relying on Rasch analysis to identify and remove items that performed poorly in terms of fit to the model. The same eligibility criteria were used, but participants had to be taking at least 2 prescription or nonprescription medications.
For each field test, questionnaire responses were double entered into Microsoft Excel, then audited and cleaned before being uploaded into SPSS (version 23) and Winsteps 34 for Rasch analysis. The Rasch rating scale model 35 estimates the probability that a respondent will choose a particular response option for an item. Rating scale categories (item responses) are ordered steps on the measurement scale. Rasch analysis places persons (respondents) and items (medication problems) on the same measurement scale where the unit of measurement is the logit (log odds unit). Reliability scores indicate how reliably persons and items are placed on the scale. Winsteps generates a hierarchy of item "severity," displayed as a "ruler," based on the frequency of item endorsement. 34 In this study, a "high severity medication problem" appears closer to the top of the Rasch ruler, whereas a "low severity medication problem" is found closer to the bottom. More severe items are described as "difficult" to endorse because they are less frequently experienced (ie, difficulty is not related to respondents' level of understanding); less severe items are more frequently experienced.
The Rasch model requires unidimensionality. This study used >30% and <15% variance as the criteria for the first (explained) and second (residual) variance dimensions, respectively, which is a rigorous test. [36] [37] [38] Dimensionality was also tested using a 3:1 ratio of variance explained by the measurement dimension to variance explained by the first principal component of residuals. 39 In order to "fit the model," persons who endorse more severe items should also endorse less severe items. Rasch analysis provides infit and outfit statistics for both persons and items. 40 Person fit indicates the extent to which each respondent's performance is consistent with the way items are used by other respondents. Item fit indicates the extent to which the use of a particular item is consistent with the way respondents have answered other items. Values less than 1.33 for both infit and outfit are considered acceptable. 41 "Misfits" can be examined qualitatively to determine whether items have confusing wording or assess a construct that is different from the one being measured, which assists with improving or dropping items.
Internal consistency reliability was determined using a standard of .80 person reliability and Cronbach's alpha. If the rating scale functions properly, outfit mean squares should be less than 2.0, average measures advance monotonically with each category and step calibrations increase monotonically. 42, 43 If the measure is appropriate for the target population, enough persons should endorse each item to enable statistical analysis.
Developing Patient-Centered Materials
During phase 3 of the study, researchers facilitated 4 stakeholder focus groups, 2 with older adults and 2 with professionals, to seek input on the name, instructions, and layout of the questionnaire; the wording of the items and response categories were not changed. Their input also led to the creation of an educational piece to accompany the questionnaire.
Phase 1 Results
Fifty-seven individuals from the 3 stakeholder groups (older adults, health-care professionals, and social workers) participated in one or more concept mapping activities. To ensure that concept mapping included the patient perspective, a total of 19 older adults, ranging in age from 61 to 87 years, were involved in one or more data collection activities during phase 1. A majority of the older participants were white, were female, and had completed at least some college. A more detailed description of participants from each stakeholder group for each concept mapping activity is provided in Table 1 .
Researchers facilitated separate in-person brainstorming sessions with older adults (n ¼ 10), health-care professionals (n ¼ 11), and social workers (n ¼ 12) to elicit statements; 3 physicians participated in an online brainstorming session using Concept System Global MAX. Brainstorming sessions generated 470 statements, which were then consolidated and reviewed by the researchers and the advisory committee, to eliminate redundancies, redraft similar statements to clarify meaning, and rewrite overly specific statements. Four cognitive interviews with a social worker, an older adult, a community nurse, and a social service researcher were conducted to finalize wording and remove any remaining unclear statements. These participants were white and ranged in age from 37 to 69 years.
The reduction process resulted in 72 statements (Appendix A), which were sorted and rated by 39 participants (described in Table 1 ). Concept System Global MAX was used to analyze the sorting data, via a stepwise cluster reduction interpretative process of alternative configurations for a visual cluster map (eg, 10 clusters, 9 clusters, etc). Researchers and the advisory committee participated in an interpretation session to achieve consensus on a concept map that best reflected parsimony of clusters without obscuring the distinction between them and assigned labels to each cluster. 25 The final map displays the 72 statements as sorted into 6 clusters: (1) confusion, (2) control over medications, (3) deception, (4) beliefs about medications, (5) problems taking medications, and (6) interpersonal and systemic factors. Statements in each cluster are listed in Appendix A.
The 6 clusters fell into 2 conceptual areas or "regions of meaning"
25 (see Figure 1 ). The region "internal and external factors" encompassed problems or issues stemming from older adults' functional difficulties, relationships with caregivers or others, or problems related to medication access or dispensing mode. The second region of meaning, "personal control factors," included general approaches to medications, as well as medication use choices and preferences.
The mean score of all participants' ratings for each statement along the 2 dimensions of prevalence and importance (see Appendix A) was used to select statements that could serve as items in the questionnaire, mainly those items derived from statements that were rated high for prevalence and importance. However, the questionnaire included a few statements rated low for prevalence and importance because they addressed issues deemed important in the literature on problematic medication use.
Feedback on a draft of the questionnaire was elicited from 2 focus groups, 1 with 6 older adults and 1 with 4 health professionals and 4 social workers (described in Table 1 ). These participants shared their interpretations of the instructions, statements, and response options and provided comments on the overall questionnaire format. As a final test of face validity, cognitive interviews with 3 older adults provided additional feedback on the wording, readability, format, and clarity of meaning. The participants included 2 women and 1 man; 2 were African American and 1 was white; and 1 had completed high school while 2 had completed college or technical training.
The resulting 40-item questionnaire included statements from each of the 6 clusters in the concept map and also reflected a breadth of patient-level factors evident in the literature on medication use problems.
1,14,44,45

Phase 2 Results
Forty-Item Questionnaire
A total of 377 eligible individuals completed the 40-item questionnaire. They ranged in age from 55 to 98 years with a mean age of 76.0 (standard deviation [SD] 8.69); nearly three quarters (71.1%) were female and 77.7% were Caucasian. Table 2 includes more details regarding participants' demographic characteristics and the number of medications taken regularly.
Winsteps 30 included 302 (80.1%) cases in the analysis (ie, those that endorsed a mix of responses). Rasch analysis showed that the questionnaire met criteria for unidimensionality. The explained variance in the 40 items was 29.4% (slightly below the criterion of >30%). The residual variance explained by the first contrast was very small, 8.4% (<15%), suggesting there was no rival dimension, that is, the ratio of the variance of the measurement dimension (29.4%) to the variance of the first principal component (8.4%) was greater than 3:1. Only a few items failed to meet criteria for model fit, in that they had both or either infit and/or outfit greater than 1.33. The rating scale functioned poorly in the sense of having disordered categories for 12 items. Person reliability was low, at .68, below the .70 cutoff. However, item reliability was good at .94 and Cronbach's alpha was .92. The sample was poorly targeted as 75 (19.9%) persons had a score of 0, indicating no medication problems (ie, floor effect), and there was a fairly large difference of 2.5 logits between the item mean of 0 and the person mean of À2.57. These results were used to remove some items that failed to meet the criteria for model fit or functioned poorly in the rating scale. However, the poorest performing item ("How often have you taken medications with alcohol even when you are not supposed to?") was retained, as it was one of the few items from cluster 3 (deception), which also addressed a higher risk for medication misuse. With the aim of improving rating scale functionality, response options were reduced from 4 (never, rarely, sometimes, and frequently) to 3 (never, once in a while, and often). The 3 response options were designed to maximize clarity and likelihood of honest responses 46 as compared to a simple yes/no response, which respondents could perceive as judgmental. To improve sample targeting for the field test of the shorter questionnaire, the eligibility criterion for the number of medications was increased to 2 or more medications. The use of these findings produced a 24-item screening tool.
Twenty-Four-Item Screener
A total of 306 eligible individuals completed the 24-item screener. Participants ranged in age from 55 to 98 years, with a mean age of 74.6 (SD 8.86). Over half (63.8%) were female; 54.7% were Caucasian, and 41.7% were African American; the remainder were Asian or other. Just over half of participants reported incomes below US$24 000, and 25.3% had only high school or less education. Approximately, half lived alone and less than 10% indicated that someone helped them with their medications. A majority (82.4%) took 3 or more medications on a regular basis, with a median of 4 medications. Winsteps 34 included 276 (90.2%) cases in the Rasch analysis (ie, those who endorsed a mix of responses). The 24-item version met criteria for unidimensionality. The explained variance was 32.2% (>30%) and the residual variance explained by the first contrast was 9.1% (<15%), which is better than a 3:1 ratio. One item (23) had infit and outfit scores that nearly met the 1.33 standard and did not meet the criterion for ordered categories. A 1.33 standard is a very stringent criterion; 1.5 is commonly used. If useful item is close to the fit criterion, it is acceptable to keep it for testing with future samples. This item was retained because it addressed the inappropriate use of potentially addictive medications and represented cluster 3 (deception) in the concept map. Overall, the rating scale functioned properly. Person reliability was good at .74, item reliability was excellent at .96, and Cronbach's alpha was high at .87.
The 24-item screener was better targeted than the 40-item version, in that a lower percentage of persons endorsed "never" for all items for a total score of 0 (9% vs 19.9%). Figure 2 shows the distribution of endorsed items along a measurement scale in logits, ranging from þ2 to À5. The item mean is at the 0 point (midpoint on the ruler). "Endorsement" of a particular item was defined as selecting a response of "once in a while" or "often." Persons endorsing fewer items are arranged at the bottom, and those endorsing many items are at the top (displayed left of a vertical dashed line on the ruler). The person mean was 2.7.
Targeting was improved since the floor effect dropped from 75 persons (19.9%) to 30 persons (9.8%) in the 24-item version. The difference between the person mean and the item mean was À2.59 logits, about the same as in the 40-item version. Appendix B includes a list of items with variable names and the percentage of endorsements, grouped by how they clustered on the Rasch hierarchy in 3 overall ranges that reflect high, moderate, and low "severity."
Seven items in the high severity range, endorsed by 5.2% to 14.4% of participants, addressed the following issues: going to more than 1 health-care provider, needing help with taking medications, not liking the method of use, inability to read or hear instructions, complicated instructions, fear of addiction, and taking potentially addictive medication when not needed. Thirteen items clustered in the moderate severity range on the hierarchy were endorsed by anywhere from 17.3% to 32.7% of participants. These addressed a wide variety of issues ranging from medication beliefs and preferences to lack of information and barriers to properly use medications. Using alcohol with medications when instructed not to fall on the least frequently endorsed end of this range (18.7%), suggesting it was a somewhat more "severe" item. Four items fell in the low severity range on the hierarchy, endorsed by anywhere from 40.5% to 64.4% of participants, suggesting these are common and potentially more "benign" problem. These items included taking medications without knowing how they interact, changes in routines, hassles with getting medications, and forgetting to take medications. The 24 items also reflect each of the 6 clusters in the concept map; Appendix B lists the cluster and statement numbers from which items were derived.
Phase 3 Results
Phase 3 focus groups provided input on the final format and layout of the questionnaire and its name. Participants included 14 older adults (4 of whom also participated in phase 1) and 24 professionals (8 of whom also participated in phase 1). The final format of the 24-item screener was informed by design principles that accommodate age-associated changes in visual and cognitive processing. 47 Features include adequate use of white space and contrast, in context instructions, elements that facilitate eye tracking, and a booklet format to minimize skipped pages, as well as a large font version. Older adult participants also provided meaningful input regarding definitions for key terms, such as "health-care provider" and "medications," questionnaire instructions, wording and format of items, and questionnaire layout. For instance, they felt items were more understandable if they were formatted to repeat the question stem in each item and also included examples. As a result, some items were longer or contained long words, resulting in a higher than desired Flesch-Kincaid readability score, at the 8.6 grade level. The questionnaire is now called the MedUseQ; Appendix C.
During phase 2 field tests, participants' comments about their experiences answering the questionnaire, along with requests for more information about medication use, suggest that the questionnaire may itself improve awareness of medication use problems. Participants also expressed a desire for an educational piece that provided ideas on how responses could be used. To respond to this need, phase 3 focus group participants assisted with developing a companion piece entitled, "Strategies for Managing Your Medications." This document provides 2 to 4 suggested action steps for each item in the questionnaire endorsed as "once in a while" or "often."
Discussion
The MedUseQ is a unidimensional measure that has acceptable person reliability and item reliability. The low person reliability of the 40-item screener was possibly due to a poorly targeted sample that did not sufficiently represent older adults experiencing medication use problems. Improvements in the 24-item screening tool, as compared to the 40-item version, were likely due in part to improved targeting, as well as selection of better fitting items and the use of the 3-point rating scale with properly ordered categories. The MedUseQ's value is its (1) broad focus on risks for prescription and nonprescription medication nonadherence, misuse, and abuse, whether unintentional or intentional, (2) recognition of patients' perspectives on their medication use, (3) utility for identifying potential problems across a range of severity from low to high, (4) potential for triggering discussions about medication use that could lead to further intervention or assessment, (5) strong psychometric properties, for example, reliability and validity using rigorous Rasch criteria, (6) user-friendly readability and a validated, user-friendly response scale, and (7) relatively short length using "best" items based on multiple criteria. The items address patient-level behaviors (eg, forgetfulness, incorrect use or dosing, inconvenience of the medication), barriers (eg, adverse effects, difficulty refilling prescriptions), and beliefs (eg, not thinking a medication works) included in prescription medication adherence tools. 48 They also address issues not typically included such as sense of control (eg, deciding on their own what medications to take), support (eg, not having someone to help with medications), and risks for misuse or abuse (eg, taking more medication than needed, drinking alcohol with medications, and going to more than 1 doctor to get more of a medication).
Problems Taking Medications
The concept mapping process captured older adults, pharmacists, nurses, and social workers views of medication use problems in the form of statements about reasons for or ways that older adults misuse or abuse medication. Knowing patients' reasons for using or not using medications is important for tailoring meaningful medication management education or services. 13, 48 Endorsement of even a single moderate to low severity item is intended to prompt the older adult to seek advice or information from a health-care professional, while a response of "often" on a high severity item suggests the need for immediate intervention. More severe items on the Rasch hierarchy could indicate a need for more comprehensive or specific assessment of medication misuse or abuse, as no one tool can address all medication-related problems. 7, 48 The MedUseQ meets needs for an easy-to-use screener that is applicable to an entire medication regimen,7 as most adherence tools have been validated in specific disease populations. 48 It is designed for community-dwelling older adults who manage the own medications. Patients could complete the 24-item screening tool in about 10 minutes in a pharmacy, clinical, social work, or other health-care setting, while waiting for a prescription, doctor visit, or services, and there is some evidence for the feasibility of using similar self-administered screeners in primary care settings. 49 The MedUseQ is most appropriate for regular monitoring but may be useful to administer after medication changes, such as during transitions in care. It could be used to efficiently identify referrals to a pharmacist or other health-care professional for consultation, comprehensive assessment, or medication, as older persons may be more likely to accept such referrals after independently completing a screener. 13 Anecdotally, respondents commented that completing the screener encouraged them to learn more about their medications. Other research has found that patients, particularly older adults, who understood and completed a screener and discussed results with a pharmacist, reported improved medication knowledge and better understanding of pharmacists' role. 13 Alternatively, patients could complete the screener on their own as part of an educational program and discuss action steps associated with each item. Using screening tools during group education can improve patient receptivity to referral for medication management therapy or other services. 7, 16 Patients could also share their responses with a health-care professional on their own.
MEASURE PERSON-MAP-ITEM
Study Limitations
Relying on convenience samples limits results in several ways. Since a majority of study participant were female and white, the views of men or people from other racial or ethnic groups may not be well represented. The physician perspective was not adequately captured in the concept map, as only 3 physicians participated. Study participants lived in a large urban environment and a majority of phase 2 participants attended area senior centers; different issues could be more salient for those living in rural areas or who are more isolated. While African Americans and whites were well represented and the percentage of Asians in the sample aligns with the percentage of older Asians living in Chicago (less than 6% of the total population of all ages), Latinos and other ethnic groups were underrepresented. In addition, a substantial percentage of field test participants were relatively well educated (see Table 2 ) and neither literacy nor health literacy was assessed.
Devising understandable items for older adults to assess their unintentional misuse of medications (eg, taking different medications with the same active ingredient) was particularly challenging, as they may not be aware of such issues. More rigorous assessment would be needed to fully assess specific forms of misuse or abuse. Finally, the tool has not yet been tested in pharmacy, clinical, or other health service settings, which could affect self-report responses.
Directions for Research
This study did not develop a cutoff score, which may not be meaningful because this screener does not focus on a particular condition or class of medications. Researchers have suggested a limited role for cutoff scores on similar tools assessing medication-related problems and some instead identify levels of adherence. 13, 18, 46 Developing a scoring protocol could be useful for determining whether a higher score or score exceeding a designated cutoff is related to confirmed medication problems.
Additional research is needed to determine the extent to which the MedUseQ compares to similar measures and its predictive value for correctly identifying individuals at risk of medication-related problems. Further psychometric analysis may identify a smaller number of items that could perform effectively as a briefer tool. Validation of translated versions for specific ethnic or racial, rural, and low literacy populations would broaden its utility.
More research is needed regarding how clinicians, pharmacists, and other health-care providers perceive the value of patient-reported information about medication use, health-care professionals' preferences for using screening tools in practice, and the impact of using such screeners on work flow. Validation of an online version could also be useful for targeting baby boomers and younger cohorts who are more likely turn to the Internet for health information as they age.
Conclusion
As a self-administered, age-friendly screening tool developed with input from older adults and other stakeholders, the MedUseQ has the potential to empower older patients to engage in conversations about potential medication use problems with pharmacists, health-care, and other service providers. In addition, the MedUseQ suggests steps that can be taken to address identified medication use problems.
Appendix A 24. How often have you gone to more than 1 health-care provider because you needed or wanted more of a medication than prescribed?
a The questionnaire, instructions, and companion educational piece are available for download at: https://www.cje. net/research-education/lsri/meduseq.
